Kyle Kuszpit

Kyle Kuszpit is currently the Associate Director and Head of Preclinical PET/CT Imaging at AstraZeneca, a position held since 2021. Previously, Kyle served as an Associate Principal Scientist and Senior Scientist within AstraZeneca's Preclinical PET/CT Imaging team from 2019 to 2021. With a strong background in preclinical imaging, Kyle has worked in various scientific roles, including Senior Research Associate II at the University of Michigan from 1996 to 2001, where they conducted PET studies on neurodegeneration and developed novel radioligands. Their expertise spans immuno-oncology, oncology, neuroscience, and multiple disease applications.